Ferroptosis as an emerging target in inflammatory diseases

Prog Biophys Mol Biol. 2020 Sep:155:20-28. doi: 10.1016/j.pbiomolbio.2020.04.001. Epub 2020 Apr 18.

Abstract

Cell survival or death is one critical issue in inflammatory responses. Ferroptosis, which is characterized by iron-dependent lethal lipid peroxidation, has been found to participate in the development of cancers, degenerative brain diseases and ischemia-reperfusion injuries. Incorporation of polyunsaturated fatty acids (PUFAs) into cellular membranes represents a vulnerability to invasion of microbials and sterile stimuli. In addition, the competition for iron in the battle between microbials and host cells underlies infection development. Although host cells have been equipped with complex antioxidant systems to combat lethal accumulation of lipid peroxidation, emerging evidence suggests several pathogens may target PUFAs in the cell membrane, and manipulate ferroptosis as a way for pathogen propagation. Moreover, ferroptosis takes part in the progression of sterile inflammations, such as cigarette smoke-induced chronic obstructive pulmonary disease, stroke and ischemia-reperfusion injuries. As iron-dependent oxidative stress and lipid peroxidation are common features for ferroptosis and inflammatory diseases, underlying mechanisms linking such pathological conditions will be discussed in this review. Progress in the research of ferroptosis may shed more light on the etiology and treatment of inflammatory diseases.

Keywords: Cell death; Ferroptosis; Inflammation; Iron; Lipid peroxidation; Polyunsaturated fatty acids.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Atherosclerosis / metabolism
  • Atherosclerosis / pathology
  • Ferroptosis / drug effects*
  • Glutathione / metabolism
  • Humans
  • Infections / metabolism
  • Infections / pathology
  • Inflammation / drug therapy*
  • Inflammation / metabolism
  • Inflammation / pathology
  • Iron / metabolism
  • Iron Chelating Agents / pharmacology
  • Iron Chelating Agents / therapeutic use*
  • Lipid Peroxidation
  • Lipoxygenases / metabolism
  • Membrane Lipids / metabolism
  • Oxidative Stress
  • Piperazines / metabolism
  • Reactive Oxygen Species / metabolism
  • Reperfusion Injury / metabolism
  • Reperfusion Injury / pathology
  • Stroke / metabolism
  • Stroke / pathology

Substances

  • Iron Chelating Agents
  • Membrane Lipids
  • Piperazines
  • Reactive Oxygen Species
  • erastin
  • Iron
  • Lipoxygenases
  • Glutathione